Business Context and Reporting Period
This Form 8-K Current Report was filed by Bicara Therapeutics Inc. on August 21, 2026. The filing discloses the entry into a material definitive agreement regarding the company's new corporate headquarters.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. Specific financial details related to the new agreement include:
- Security Deposit: $210,540 paid upon entry into the agreement.
- Base Rent: $105,279 per month.
- Rent Commencement: Payable nine months following the Commencement Date.
- Lease Term: Ends on the earlier of September 30, 2028, or termination date.
Material Changes
The primary material change is the execution of a Sub-Sublease Agreement with Wayfair LLC for approximately 35,090 square feet of office space at 10 St. James Avenue, Boston, Massachusetts. The lease term commences on the later of October 1, 2026, or the date of full execution of necessary consents from the landlord and overlandlord.
Outlook and Management Commentary
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies beyond the standard covenants and events of default customary to the lease agreement. The document focuses solely on the terms of the new headquarters lease.
Investor Verification Checklist
- Verify the execution of the consent between Bicara Therapeutics, Wayfair LLC, Liberty Mutual Insurance Company, and MT Back Bay One LLC to confirm the actual Commencement Date.
- Confirm the impact of the $210,540 security deposit and future rent obligations on the company's current liquidity position.
- Review the full text of the Sub-Sublease Agreement (Exhibit 10.1) for specific termination clauses and default conditions.